[PDF][PDF] Uptake of drug-carrier liposomes by placenta: transplacental delivery of drugs and nutrients.
SN Tüzel-Kox, HM Patel, WJ Kox - Journal of Pharmacology and …, 1995 - Citeseer
Liposomes with different charge, size and lipid composition were injected iv into pregnant rats
and rabbits and their uptake and transport across the placenta were studied. Results show …
and rabbits and their uptake and transport across the placenta were studied. Results show …
[CITATION][C] Uptake of drug-carrier liposomes delivery of drugs and nutrients by placenta: transplacental
SNT Kox, HM Patel, WJ Kox - J. Pharmacol. Exp. Ther, 1995
[HTML][HTML] Recent Genome-Editing Approaches toward Post-Implanted Fetuses in Mice
S Nakamura, E Inada, I Saitoh, M Sato - BioTech, 2023 - mdpi.com
… SN and MS conceived and designed this study and drafted and revised the manuscript; EI
and IS critically revised the manuscript. All authors have read and agreed to the published …
and IS critically revised the manuscript. All authors have read and agreed to the published …
Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia
L Valero, K Alhareth, S Gil, E Lecarpentier… - Drug Discovery …, 2018 - Elsevier
… An early and extensive study was conducted by Tuzel-Kox et al. [49] to explore the potential
of liposomes to deliver drugs to the fetoplacental unit. Liposomes with different surface …
of liposomes to deliver drugs to the fetoplacental unit. Liposomes with different surface …
[BOOK][B] Pharmacokinetics of phospholipid formulations of AZT in the pregnant rat
AT Eley - 1999 - search.proquest.com
INFORMATION TO USERS Page 1 INFORMATION TO USERS This manuscript has been
reproduced from the microfilm master. UMI films the text directly from the original or copy …
reproduced from the microfilm master. UMI films the text directly from the original or copy …
Liposomes: a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model
Objective Indomethacin (IND) is a prostaglandin production inhibitor that reduces uterine
contractions, but crosses the placenta leading to adverse fetal effects. Liposomes (LIP) are …
contractions, but crosses the placenta leading to adverse fetal effects. Liposomes (LIP) are …
[BOOK][B] Targeted Delivery of Nanotherapeutics to the Placenta
A King - 2016 - search.proquest.com
During pregnancy the placenta is responsible for ensuring sufficient nutrient transfer and
gaseous exchange between the maternal and fetal circulations. Fetal growth restriction (FGR), …
gaseous exchange between the maternal and fetal circulations. Fetal growth restriction (FGR), …
[BOOK][B] Gentamicin-modified Nanocarriers for Placental Targeted Drug Delivery to Treat Pregnancy-related Complications
A Alfaifi - 2019 - search.proquest.com
Diseases of pregnancy are the leading cause of maternal and neonatal morbidity and mortality
affecting more than 20%(26 million) of all pregnancies annually. Those diseases include …
affecting more than 20%(26 million) of all pregnancies annually. Those diseases include …
Size of the nanovectors determines the transplacental passage in pregnancy: study in rats
JS Refuerzo, B Godin, K Bishop, S Srinivasan… - American journal of …, 2011 - Elsevier
OBJECTIVE: The objective of the study was to examine whether the size of silicon nanovectors
(SNVs) inhibits their entrance into the fetal circulation. STUDY DESIGN: Pregnant rats …
(SNVs) inhibits their entrance into the fetal circulation. STUDY DESIGN: Pregnant rats …
Drug delivery during pregnancy: how can nanomedicine be used?
MD Joshi - Therapeutic Delivery, 2017 - Future Science
According to the CDC [1], about 90% of women take at least one medication during pregnancy
and 70% take at least one prescription medication. Over the last 30 years, the use of …
and 70% take at least one prescription medication. Over the last 30 years, the use of …